Oliver Sol
Chief Tech/Sci/R&D Officer bei AC IMMUNE SA
Profil
Oliver Sol is currently working as the VP & Head-Clinical Development at AC Immune SA. Previously, he worked as the Clinical Director at Exonhit and as the Director-Medical & Regulatory Affairs at Eurobio-Scientific SA. Dr. Sol holds a doctorate degree from Université de Paris XI Paris Sud.
Aktive Positionen von Oliver Sol
Unternehmen | Position | Beginn |
---|---|---|
AC IMMUNE SA | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Oliver Sol
Unternehmen | Position | Ende |
---|---|---|
EUROBIO SCIENTIFIC | Chief Tech/Sci/R&D Officer | - |
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Oliver Sol
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
AC IMMUNE SA | Health Technology |
EUROBIO SCIENTIFIC | Health Technology |
Private Unternehmen | 2 |
---|---|
Exonhit
Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
Université de Paris XI Paris Sud | Consumer Services |